Event Date/Time: Mar 31, 2004
End Date/Time: Apr 02, 2004
IIR's "Pipeline: Portfolio Strategy Congress" is a 4-tracked large scale event with over 75 senior-level speakers, addressing key business strategy issues for the pharmaceutical and biotechnology industries. This event seeks program speaking and delegate participation of very senior level VP/Director level business development and licensing executives on leading strategies in licensing, strategic alliances, mergers and acquisitions, biotechnology financing, technology financing and intellectual property. The program sessions will focus on best practices and case studies on the use of creative new deal structures, success and failure stories of bio/pharma partnering, and how biotechnology companies are raising capital to stay alive if they are not getting the deals to fund their research. Several keynote addresses focus on the impact of consolidation in the industry, the future of R & D/technology spending, state of deal structures overall and more.